2001
DOI: 10.2169/internalmedicine.40.805
|View full text |Cite
|
Sign up to set email alerts
|

Hypothalamic Encephalitis with Bradycardia.

Abstract: A 74-year-old man developed fever, somnolence, hyponatremia, and life-threatening sinus bradycardia for three weeks. He showed a slight elevation of lymphocyte count and protein level in the cerebrospinal fluid. A brain CT scan revealed a diffuse low density area around the hypothalamus which was identified as a high intensity signal by flair MR imaging. Marked sinus bradycardia developed with no abnormality in the echocardiograph or cardiac enzymes. Over the next 6 weeks he became alert and normal sinus rhyth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…To the best of our knowledge, no previous reports of neurovegetative/autonomic alterations have been ever described in EAATD. On the contrary, a few cases of bradycardia and hypothermia secondary to infectious or autoimmune hypothalamic or limbic encephalitis have been reported [20][21][22][23]. In particular, hypothermia and haemodynamic changes consistent with autonomic dysfunction have been observed in patients with anti-Ma-2 Abs, anti-NMDA receptor Abs, and anti-VGKC Abs, the latter targeting usually the hippocampus and the mesial temporal lobe [24,25].…”
Section: Discussionmentioning
confidence: 99%
“…To the best of our knowledge, no previous reports of neurovegetative/autonomic alterations have been ever described in EAATD. On the contrary, a few cases of bradycardia and hypothermia secondary to infectious or autoimmune hypothalamic or limbic encephalitis have been reported [20][21][22][23]. In particular, hypothermia and haemodynamic changes consistent with autonomic dysfunction have been observed in patients with anti-Ma-2 Abs, anti-NMDA receptor Abs, and anti-VGKC Abs, the latter targeting usually the hippocampus and the mesial temporal lobe [24,25].…”
Section: Discussionmentioning
confidence: 99%